Curi Bio raises $10M Series A to advance Mantarry stem cell drug-discovery platform

Seattle startup Curi Bio raised $10 million in Series A to advance its Mantarry stem cell-focused drug discovery platform and expand the business.

More: Curi Bio, GeekWire

No comments yet.